0 Ratings
ID

35510

Description

Study ID: 101468/194 Clinical Study ID: 101468/194 Study Title: A 12 Week, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Efficacy and Safety of Ropinirole in Patients Suffering from Restless Legs Syndrome (RLS). Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: requip Study Indication: Restless Legs Syndrome

Keywords

Versions (1)
  1. 3/6/19 3/6/19 -
Copyright Holder

GlaxoSmithKline

Uploaded on

March 6, 2019

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

  • Newest
  • Oldest
  • Popular
  • Newest
    • Newest
    • Oldest
    • Popular

    No comments

    In order to download data models you must be logged in. Please log in or register for free.

    Ropinirole in Patients with Restless Legs Syndrome (Study ID: 101468/194)

    English

    Concomitant Medication

    1 forms  
    1. StudyEvent: ODM
      1. Concomitant Medication
    Administrative data
    Description

    Administrative data

    Alias
    UMLS CUI-1
    C1320722
    Centre Number
    Description

    Study Coordinating Center, Identification number

    Data type

    integer

    Alias
    UMLS CUI [1,1]
    C2825181
    UMLS CUI [1,2]
    C1300638
    Patient Number
    Description

    Clinical Trial Subject Unique Identifier

    Data type

    integer

    Alias
    UMLS CUI [1]
    C2348585
    Patient Initials
    Description

    Person Initials

    Data type

    text

    Alias
    UMLS CUI [1]
    C2986440
    Concomitant Medication
    Description

    Concomitant Medication

    Alias
    UMLS CUI-1
    C2347852
    Please mark if no new or change in concomitant medication since the previous visit.
    Description

    Concomitant Agent, No status change

    Data type

    boolean

    Alias
    UMLS CUI [1,1]
    C2347852
    UMLS CUI [1,2]
    C0442739
    Drug Name (Trade Name Preferred)
    Description

    Concomitant Agent, Medication name

    Data type

    text

    Alias
    UMLS CUI [1,1]
    C2347852
    UMLS CUI [1,2]
    C2360065
    Total Daily Dose
    Description

    Concomitant Medication Daily Dose, Total

    Data type

    text

    Alias
    UMLS CUI [1,1]
    C2826638
    UMLS CUI [1,2]
    C0439810
    Medical Illness/ Diagnosis (or symptom in absence of diagnosis)
    Description

    Concomitant Agent, Disease

    Data type

    text

    Alias
    UMLS CUI [1,1]
    C2347852
    UMLS CUI [1,2]
    C0012634
    Start Date (be as precise as possible)
    Description

    Concomitant Medication Start Date

    Data type

    date

    Alias
    UMLS CUI [1]
    C2826734
    End Date
    Description

    Concomitant Medication End Date

    Data type

    date

    Alias
    UMLS CUI [1]
    C2826744
    If Continuing mark box
    Description

    Concomitant Medication Ongoing

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C2826666
    Back to the top of the page

    Similar models

    Concomitant Medication

    1 forms
    1. StudyEvent: ODM
      1. Concomitant Medication
    Name
    Type
    Description | Question | Decode (Coded Value)
    Data type
    Alias
    Item Group
    Administrative data
    C1320722 (UMLS CUI-1)
    Study Coordinating Center, Identification number
    Item
    Centre Number
    integer
    C2825181 (UMLS CUI [1,1])
    C1300638 (UMLS CUI [1,2])
    Clinical Trial Subject Unique Identifier
    Item
    Patient Number
    integer
    C2348585 (UMLS CUI [1])
    Person Initials
    Item
    Patient Initials
    text
    C2986440 (UMLS CUI [1])
    Item Group
    Concomitant Medication
    C2347852 (UMLS CUI-1)
    Concomitant Agent, No status change
    Item
    Please mark if no new or change in concomitant medication since the previous visit.
    boolean
    C2347852 (UMLS CUI [1,1])
    C0442739 (UMLS CUI [1,2])
    Concomitant Agent, Medication name
    Item
    Drug Name (Trade Name Preferred)
    text
    C2347852 (UMLS CUI [1,1])
    C2360065 (UMLS CUI [1,2])
    Concomitant Medication Daily Dose, Total
    Item
    Total Daily Dose
    text
    C2826638 (UMLS CUI [1,1])
    C0439810 (UMLS CUI [1,2])
    Concomitant Agent, Disease
    Item
    Medical Illness/ Diagnosis (or symptom in absence of diagnosis)
    text
    C2347852 (UMLS CUI [1,1])
    C0012634 (UMLS CUI [1,2])
    Concomitant Medication Start Date
    Item
    Start Date (be as precise as possible)
    date
    C2826734 (UMLS CUI [1])
    Concomitant Medication End Date
    Item
    End Date
    date
    C2826744 (UMLS CUI [1])
    Concomitant Medication Ongoing
    Item
    If Continuing mark box
    boolean
    C2826666 (UMLS CUI [1])
    Back to the top of the page 

    Help

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial